ORLA Q1 2026 Earnings Slight EPS Miss but Stock Gains 496 TIPT Q2 2025 Earnings EPS of 058 Reported Amid Modest Stock Decline Castle Biosciences Q1 2026 Earnings Narrowly Beats EPS Estimates but Stock Declines GOOD Q1 2026 Earnings Strong EPS Beat Despite Negative Market Reaction NextCure Inc NXTC Q1 2026 Earnings EPS Beat Amid No Revenue and Steep Stock Decline USFD Q1 2026 Earnings EPS Misses Estimates but Stock Gains Amid Operational Improvements